<< Back to Article
References​
1. Macdorman MF, Gregory ECW. Fetal and perinatal mortality, United States,
2013. National vital statistics reports; vol 64 no 8. Hyattsville, MD:
National Center for Health Statistics. 2015.
2. Romero R, Chaiworapongsa T, Erez O. An imbalance between angiogenic and
anti-angiogenicfactors precedes fetal death in a subset of patients: results
of a longitudinal study. J Matern Fetal Neonatal Med. 2010 May 12.10.3109/14767051003681121
3. Gardosi J, Kady SM, McGeown P, Francis A,Tonks A. Classification of stillbirth
by relevant condition at death (ReCoDe): population based cohort study.
BMJ. 2005; 331:1113–1117.
4. Lee J, Romero R, Dong Z, Xu Y, Qureshi F, Jacques S, Yoo W, Chaiworapongsa
T, Mittal P, Hassan SS, Kim CJ. Unexplained fetal death has a biological
signature of maternal anti-fetal rejection: chronic chorioamnionitis and
alloimmune anti-human leucocyte antigen antibodies. Histopathology. 2011
Nov; 59(5):928-38.
5. Nielsen HS, Witvliet MD, Steffensen R, et al. The presence of HLA-antibodies
in recurrent miscarriage patients is associated with a reduced chance
of a live birth. J Reprod Immunol. 2010 Jul 3.
6. Nielsen HS, Steffensen R, Varming K, Van Halteren AG, Spierings E, Ryder
LP, Goulmy E, Christiansen OB. Association of HY-restricting HLA class
II alleles with pregnancy outcome in patients with recurrent miscarriage
subsequent to a firstborn boy. Hum Mol Genet. 2009 May 1; 18 (9):1684-91.
7.Romero R, Whitten A, Korzeniewski SJ, Than NG, Chaemsaithong P, Miranda
J, Dong Z, Hassan SS, Chaiworapongsa T. Maternal floor infarction/massive
perivillous fibrin deposition: a manifestation of maternal antifetal rejection?
Am J Reprod Immunol. 2013 Oct; 70(4):285-98.
8. Betkowski AS, Graff R, Chen JJ, Hauptman PJ. Panel-reactive antibody screening
practices prior to heart transplantation. J Heart Lung Transplant. 2002;
21:644–650.
9. Nielsen HS, Witvliet MD, Steffensen R, Haasnoot GW, Goulmy E, Christiansen
OB, Claas F. The presence of HLA-antibodies in recurrent miscarriage patients
is associated with a reduced chance of a live birth. J Reprod Immunol.
2010; 87:67–73.
10. Lee J, Romero R, Xu Y, Kim JS, Topping V, Yoo W, Kusanovic JP, Chaiworapongsa
T, Hassan SS, Yoon BH, Kim CJ. A signature of maternal anti-fetal rejection
in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte
antigen antibodies, and C4d. PLoS One. 2011; 6:e16806.
11. Espinoza J, Chaiworapongsa T, Romero R, et al. Unexplained fetal death:
another anti-angiogenic state. J Matern Fetal Neonatal Med. 2007; 20:495–507.
12. Labarrere CA, McIntyre JA, Faulk WP. Immunohistologic evidence that villitis
in human normal term placentas is an immunologic lesion. Am J Obstet Gynecol
1990; 162: 515e22.
13. Brito H, Juliano P, Altemani C, Altemani A. Is the immunohistochemical
study of the inflammatory infiltrate helpful in distinguishing villitis
of unknown etiology from non-specific infection villitis? Placenta. 2005
Nov; 26(10):839-41.
14. Myerson D, Parkin RK, Benirschke K, Tschetter CN, Hyde SR. The pathogenesis
of villitis of unknown etiology: analysis with a new conjoint immunohistochemistry-in
situ hybridization procedure to identify specific maternal and fetal cells.
Pediatr Dev Pathol 2006; 9:257e65.
15. Redline RW, Patterson P. Villitis of unknown etiology is associated with
major infiltration of fetal tissue by maternal inflammatory cells. Am
Pathol. 1993 Aug; 143(2):473-9.
16. Kim J-S, Romero R, Kim MR, Kim YM, Friel L, Espinoza J, et al. Involvement
of Hofbauer cells and maternal T cells in villitis of unknown etiology.
Histopathology 2008; 52:457e64.
17. Styer AK, Parker HJ, Roberts DJ, et al. Placental villitis of unclear etiology
during ovum donor in vitro fertilization pregnancy. Am J Obstet Gynecol
2003; 189:1184-6.
18. Perni SC, Cho JE, Baergen RN. Placental pathology and pregnancy outcomes
in donor and non-donor oocyte in vitro fertilization pregnancies. Am J
Obstet Gynecol 2003; 189:S122.
19. Yokoyama WM. The mother-child union: the case of missing-self and protection
of the fetus. Proc Natl Acad Sci U S A 1997; 94:5998-6000.
20. Derricott H, Jones RL, Heazell AE. Investigating the association of villitis
of unknown etiology with stillbirth and fetal growth restriction - a systematic
review. Placenta. 2013 Oct; 34(10):856-62.
21. Hulthén Varli I, Petersson K, Kublickas M, Papadogiannakis N. Both
acute and chronic placental inflammation are overrepresented in term stillbirths:
a case-control study. Infectious Diseases in Obstetrics and Gynecology
2012 Jan; 2012:1e8.
22. Traeder J, Jonigk D, Feist H, Bröcker V, Länger F, Kreipe H,
et al. Pathological characteristics of a series of rare chronic histiocytic
intervillositis of the placenta. Placenta 2010; 31:1116e9.
23. Mekinian A, Costedoat-Chalumeau N, Masseau A, Botta A, Chudzinski A, Theulin
A, Emmanuelli V, Hachulla E, De Carolis S, Revaux A, Nicaise P, Cornelis
F, Subtil D, Montestruc F, Bucourt M, Chollet-Martin S, Carbillon L, Fain
O; SNFMI and the European Forum of APS. Chronic histiocytic intervillositis:
outcome, associated diseases and treatment in a multicenter prospective
study. Autoimmunity. 2015 Feb; 48(1):40-5.
24. Doss, B. J., M. F. Greene, J. Hill, et al. 1995. Massive chronic intervillositis
associated with recurrent abortions. Hum. Pathol. 26: 1245–1251.
25. Labarrere C, Mullen E. Fibrinoid and trophoblastic necrosis with massive
chronic intervillositis: an extreme variant of villitis of unknown etiology.
Am J Reprod Immunol Microbiol 1987a; 15:85e91.
26. Boyd TK, Redline WR. Chronic histiocytic intervillositis: a placental lesion
associated with recurrent reproductive loss. Hum Pathol 2000; 31:1389e96.
27. Capuani C, Meggetto F, Duga I, Danjoux M, March M, Parant O, Brousset P,
Aziza J. Specific infiltration pattern of FOXP3+ regulatory T cells in
chronic histiocytic intervillositis of unknown etiology. Placenta. 2013
Feb; 34(2):149-54.
28. Tilburgs T, Scherjon SA, van der Mast BJ, Haasnot GW, Versteeg- VD, Voort-
Maarschalk M, et al. Fetal-maternal HLA-C mismatch is associated with
decidual T cell activation and induction of functional T regulatory cells.
J Reprod Immunol 2009; 82:148e57.
29. A Parant O, Capdet J, Kessler S, Aziza J, Berrebi A. Chronic intervillositis
of unknown etiology (CIUE): relation between placental lesions and perinatal
outcome. Eur J Obstet Gynecol Reprod Biol 2009; 143:9e13.
30. Mekinian A, Costedoat-Chalumeau N, Masseau A, Botta A, Chudzinski A, Theulin
A, Emmanuelli V, Hachulla E, De Carolis S, Revaux A, Nicaise P, Cornelis
F, Subtil D, Montestruc F, Bucourt M, Chollet-Martin S, Carbillon L, Fain
O; SNFMI and the European Forum of APS. Chronic histiocytic intervillositis:
outcome, associated diseases and treatment in a multicenter prospective
study. Autoimmunity. 2015 Feb; 48(1):40-5.
<< Back to Article